{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:22:36Z","timestamp":1790688156328,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.biopha.2021.111412","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T19:05:32Z","timestamp":1614193532000},"page":"111412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Therapeutic monitoring of carbamazepine and its active metabolite during the 1st postnatal month: Influence of drug interactions"],"prefix":"10.1016","volume":"137","author":[{"given":"Ivana","family":"Kacirova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Grundmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Brozmanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111412_bib1","unstructured":"EURAP, May, 2020. An international antiepileptic drugs and pregnancy registry. In: Interim Report, Available at: \u3008www.eurapinternational.org\u3009. (Accessed December 28, 2020)."},{"issue":"2","key":"10.1016\/j.biopha.2021.111412_bib2","first-page":"23","article-title":"Trend analysis of the utilization of antiepileptic drugs in pregnant women with epilepsy in Moravian-Silesian region of the Czech Republic","volume":"30","author":"Kacirova","year":"2016","journal-title":"Klin. Farmakol. Farm."},{"key":"10.1016\/j.biopha.2021.111412_bib3","unstructured":"The Drug and Lactation Database (LACTMED), A database of the National Library of Medicine's TOXNET system, \u3008https:\/\/toxnet.nlm.nih.gov\/\u3009 on December 28, 2020. (Accessed December 28, 2020)."},{"key":"10.1016\/j.biopha.2021.111412_bib4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jamapediatrics.2014.118","article-title":"Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years","volume":"168","author":"Meador","year":"2014","journal-title":"JAMA Pedia"},{"key":"10.1016\/j.biopha.2021.111412_bib5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0140-6736(87)90853-1","article-title":"Infantile spasms on weaning from breast milk containing anticonvulsants","volume":"330","author":"Knott","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.111412_bib6","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1177\/106002809202601215","article-title":"Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breast feeding","volume":"26","author":"Merlob","year":"1992","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.biopha.2021.111412_bib7","series-title":"Treatment Options and Risk Assessment","first-page":"700","article-title":"Drugs during pregnancy and lactation","author":"Schaefer","year":"2007"},{"issue":"Suppl 9","key":"10.1016\/j.biopha.2021.111412_bib8","first-page":"22","article-title":"The use of mood stabilizers during breastfeeding","volume":"68","author":"Stowe","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.biopha.2021.111412_bib9","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/aps.2012.135","article-title":"The effect of poor compliance on the pharmacokinetics of carbamazepine and its epoxide metabolite using Monte Carlo simulation","volume":"33","author":"Ding","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"issue":"11","key":"10.1016\/j.biopha.2021.111412_bib10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s40262-013-0087-0","article-title":"Drug interactions with the newer antiepileptic drugs (AEDs) - Part 1: pharmacokinetic and pharmacodynamic interactions between AEDs","volume":"52","author":"Patsalos","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.biopha.2021.111412_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.eplepsyres.2016.02.013","article-title":"Concentrations of carbamazepine and carbamazepine-10,11-epoxide in maternal and umbilical cord blood at birth: Influence of co-administration of valproic acid or enzyme-inducing antiepileptic drugs","volume":"122","author":"Kacirova","year":"2016","journal-title":"Epilepsy Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.111412_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamaneurol.2019.4443","article-title":"Antiepileptic drug exposure in infants of breastfeeding mothers with epilepsy","volume":"77","author":"Birnbaum","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.biopha.2021.111412_bib13","series-title":"Epilepsy, Pregnancy and the Child","first-page":"343","article-title":"The problems of antiepileptic medication in the neonatal period: is breast feeding advisable?","author":"Kaneko","year":"1981"},{"key":"10.1016\/j.biopha.2021.111412_bib14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00007691-198409000-00002","article-title":"Carbamazepine levels in breast milk","volume":"6","author":"Froescher","year":"1984","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.biopha.2021.111412_bib15","first-page":"199","article-title":"Carbamazepine and carbamazepine-10,11- epoxide during pregnancy and postnatal period in epileptic mothers and their nursed infants. Pharmacokinetics and clinical effects","volume":"3","author":"Kuhnz","year":"1983","journal-title":"Pediatr. Pharmacol."},{"issue":"Pt 2","key":"10.1016\/j.biopha.2021.111412_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1258\/0004563001899023","article-title":"Monitoring of carbamazepine and carbamazepine-10,11- epoxide in breast milk and plasma by high-performance liquid chromatography","volume":"37","author":"Shimoyama","year":"2000","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.biopha.2021.111412_bib17","first-page":"1195","article-title":"The perinatal pharmacokinetics of anticonvulsant drugs","volume":"110","author":"Meyer","year":"1988","journal-title":"Zent. Gynakol."},{"key":"10.1016\/j.biopha.2021.111412_bib18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0773.1977.tb02145.x","article-title":"Carbamazepine: placental transport, tissue concentrations in foetus and newborn, and level in milk","volume":"41","author":"Pynn\u00f6nen","year":"1977","journal-title":"Acta Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2021.111412_bib19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2125.1979.tb04654.x","article-title":"The levels of anticonvulsants in breast milk","volume":"7","author":"Kaneko","year":"1979","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111412_bib20","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0140-6736(82)92189-4","article-title":"Drowsiness due to clemastine transmitted in breastmilk","volume":"319","author":"Kok","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.111412_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/000992289803700107","article-title":"Fluoxetine and carbamazepine concentrations in a nursing mother\/infant pair","volume":"37","author":"Brent","year":"1998","journal-title":"Clin. Pediatr. Philos. )"},{"key":"10.1016\/j.biopha.2021.111412_bib22","first-page":"139","article-title":"Carbamazepine levels in pregnancy and lactation","volume":"53","author":"Niebyl","year":"1979","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.biopha.2021.111412_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00004714-199804000-00009","article-title":"Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs","volume":"18","author":"Wisner","year":"1998","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.biopha.2021.111412_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/bfm.2017.0235","article-title":"Maternal carbamazepine therapy and unusual adverse effects in a breastfed infant","volume":"13","author":"Antonucci","year":"2018","journal-title":"Breastfeed. Med."},{"key":"10.1016\/j.biopha.2021.111412_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jchromb.2012.01.021","article-title":"Quantification of carbamazepine and its active metabolite by direct injection of human milk serum using liquid chromatography tandem ion trap mass spectrometry","volume":"889\u2013890","author":"Lopes","year":"2012","journal-title":"J. Chromatogr. B"},{"issue":"5","key":"10.1016\/j.biopha.2021.111412_bib26","first-page":"602","article-title":"A case report of monitoring on carbamazepine in breastfeeding woman","volume":"42","author":"Zhao","year":"2010","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban."},{"key":"10.1016\/j.biopha.2021.111412_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.yebeh.2007.08.018","article-title":"Pharmacology of antiepileptic drugs during pregnancy and lactation","volume":"11","author":"Pennell","year":"2007","journal-title":"Epilepsy Behav."},{"issue":"1","key":"10.1016\/j.biopha.2021.111412_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jssc.200700253","article-title":"Simultaneous determination of antiepileptic drugs and two active metabolites by HPLC","volume":"31","author":"Budakova","year":"2008","journal-title":"J. Sep. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111412_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.131","article-title":"Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses","volume":"3","author":"Keizer","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.biopha.2021.111412_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yebeh.2014.02.011","article-title":"Carbamazepine clearance and seizure stability during pregnancy","volume":"33","author":"Johnson","year":"2014","journal-title":"Epilepsy Behav."},{"issue":"5","key":"10.1016\/j.biopha.2021.111412_bib31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/FTD.0000000000000546","article-title":"Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update","volume":"40","author":"Patsalos","year":"2018","journal-title":"Ther. Drug. Monit."},{"issue":"3","key":"10.1016\/j.biopha.2021.111412_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/FTD.0000000000000604","article-title":"A short communication: lamotrigine levels in milk, mothers and breast-fed infants during the 1st postnatal month","volume":"41","author":"Kacirova","year":"2019","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.biopha.2021.111412_bib33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yebeh.2019.04.002","article-title":"Valproic acid concentrations in nursing mothers, mature milk, and breastfed infants in monotherapy and combination therapy","volume":"95","author":"Kacirova","year":"2019","journal-title":"Epilepsy Behav."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221001979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221001979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:36:56Z","timestamp":1760099816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221001979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":33,"alternative-id":["S0753332221001979"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111412","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic monitoring of carbamazepine and its active metabolite during the 1st postnatal month: Influence of drug interactions","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111412"}}